{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T08:21:52Z","timestamp":1759134112277},"reference-count":39,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2007,5,30]],"date-time":"2007-05-30T00:00:00Z","timestamp":1180483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[2007,10]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Objective\u2002<\/jats:bold> In January 1997 we introduced a protocol for the treatment with GH of children with impaired growth after unfractionated total body irradiation (TBI). This study is an evaluation of that protocol.<\/jats:p><jats:p><jats:bold>Patients and methods\u2002<\/jats:bold> Between January 1997 and July 2005, 66 patients (48 male) treated for haematological malignancies had at least two years of disease\u2010free survival after TBI\u2010based conditioning for stem cell transplantation (SCT). Stimulated and\/or spontaneous GH secretion was decreased in 8 of the 29 patients tested because of impaired growth. Treatment with GH (daily dose 1\u00b73\u00a0mg\/m<jats:sup>2<\/jats:sup> body surface area) was offered to all 29 patients and initiated in 23 of them (17 male). The main outcome measure was the effect of GH therapy on height standard deviation scores (SDS) after onset of GH therapy, estimated by random\u2010effect modelling with corrections for sex, age at time of SCT and puberty (data analysed on intention\u2010to\u2010treat basis).<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> At time of analysis, median duration of therapy was 3\u00b72\u00a0years; median follow\u2010up after start of GH therapy was 4\u00b72\u00a0years. The estimated effect of GH therapy, modelled as nonlinear (logit) curve, was +1\u00b71 SD after 5\u00a0years. Response to GH therapy did not correlate to GH secretion status.<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold> GH therapy has a positive effect on height SDS after TBI, irrespective of GH secretion status.<\/jats:p>","DOI":"10.1111\/j.1365-2265.2007.02930.x","type":"journal-article","created":{"date-parts":[[2007,6,22]],"date-time":"2007-06-22T04:20:32Z","timestamp":1182486032000},"page":"589-597","source":"Crossref","is-referenced-by-count":24,"title":["Growth hormone (GH) secretion and response to GH therapy after total body irradiation and haematopoietic stem cell transplantation during childhood"],"prefix":"10.1111","volume":"67","author":[{"given":"B.","family":"Bakker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Oostdijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. B.","family":"Geskus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. H.","family":"Stokvis\u2010Brantsma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. M.","family":"Vossen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. M.","family":"Wit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,5,30]]},"reference":[{"key":"e_1_2_5_2_2","first-page":"163","article-title":"Growth, growth hormone and final height after BMT. Possible recovery of irradiation\u2010induced growth hormone insufficiency","volume":"18","author":"Holm K.","year":"1996","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_5_3_2","first-page":"4109","article-title":"Final height of patients who underwent bone marrow transplantation for hematological disorders during childhood: a study by the Working Party for Late Effects\u2010EBMT","volume":"93","author":"Cohen A.","year":"1999","journal-title":"Blood"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004310050006"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704324"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-07-2528"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03527.x"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1203\/01.pdr.0000199550.71887.ba"},{"key":"e_1_2_5_9_2","first-page":"E486","article-title":"Cluster analysis: a simple, versatile, and robust algorithm for endocrine pulse detection","volume":"250","author":"Veldhuis J.D.","year":"1986","journal-title":"American Journal of Physiology"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1159\/000023268"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2002.01607.x"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.51.3.170"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-200003000-00006"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.45.244.755"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2001.01188.x"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1159\/000181037"},{"key":"e_1_2_5_17_2","first-page":"183","article-title":"Growth failure and growth hormone deficiency in children after bone marrow transplantation for leukemia","volume":"5","author":"Hovi L.","year":"1990","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.66.6.689"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.67.9.1107"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V79.4.1068.bloodjournal7941068"},{"key":"e_1_2_5_21_2","first-page":"381","article-title":"Growth hormone function and treatment following bone marrow transplant for neuroblastoma","volume":"12","author":"Olshan J.S.","year":"1993","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.68.4.458"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1994.12.5.916"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.2.819.bloodjournal862819"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.2.825.bloodjournal862825"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(96)70119-1"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(97)80022-4"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702021"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1080\/088800100276271"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705455"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-06-2441"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2000.01071.x"},{"key":"e_1_2_5_33_2","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1210\/jcem.87.5.8479","article-title":"Recombinant human GH replacement therapy and thyroid function in a large group of adult GH\u2010deficient patients: when does L\u2010T (4) therapy become mandatory?","volume":"87","author":"Porretti S.","year":"2002","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2003.01892.x"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.2.348"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0656"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1159\/000067834"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004694-199805000-00016"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703424"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.10426"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.2007.02930.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.2007.02930.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T12:15:39Z","timestamp":1697199339000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.2007.02930.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,30]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["10.1111\/j.1365-2265.2007.02930.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.2007.02930.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,30]]}}}